Dependability and Prognostic Value of Biomarkers in COVID-19 Associated Rhino-Orbito- Cerebral Mucormycosis- A Long Term Ambispective Study

Overview

Journal Indian J Otolaryngol Head Neck Surg

Publisher Springer

Date 2024 Oct 8

PMID 39376422

Authors

K Nidhin Das

Diksha Gupta

Vidhu Sharma

Kapil Soni

Mithu Banerjee

Bikram Choudhury

Amit Goyal

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-024-04921-3.

References

Hoenigl M, Seidel D, Carvalho A, Rudramurthy S, Arastehfar A, Gangneux J . The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022; 3(7):e543-e552. PMC: 8789240. DOI: 10.1016/S2666-5247(21)00237-8. View

Maruna P, Nedelnikova K, Gurlich R . Physiology and genetics of procalcitonin. Physiol Res. 2000; 49 Suppl 1:S57-61. View

Dou Y, Du J, Liu H, Shong X . The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagn Microbiol Infect Dis. 2013; 76(4):464-9. DOI: 10.1016/j.diagmicrobio.2013.04.023. View

Zirpe K, Pote P, Deshmukh A, Gurav S, Tiwari A, Suryawanshi P . A Retrospective Analysis of Risk Factors of COVID-19 Associated Mucormycosis and Mortality Predictors: A Single-Center Study. Cureus. 2021; 13(10):e18718. PMC: 8584128. DOI: 10.7759/cureus.18718. View

Ghazi B, Zahid U, Usman M, Kazmi Z, Hunain R, Riaz M . Antifungal Drugs Shortage in India amidst Looming Increase in Invasive Fungal Infections among COVID-19 Patients: An Impending Crisis. Innov Pharm. 2023; 13(2). PMC: 9836748. DOI: 10.24926/iip.v13i2.4480. View

Stringer D, Braude P, Myint P, Evans L, Collins J, Verduri A . The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol. 2021; 50(2):420-429. PMC: 7989395. DOI: 10.1093/ije/dyab012. View

Urbanowicz T, Michalak M, Olasinska-Wisniewska A, Perek B, Rodzki M, Wachowiak-Baszynska H . Neutrophile-to-Lymphocyte Ratio as a Predictor of Mortality and Response to Treatment in Invasive Aspergillosis among Heart Transplant Recipients-Exploratory Study. Medicina (Kaunas). 2021; 57(12). PMC: 8703887. DOI: 10.3390/medicina57121300. View

Nayak P, Katyal I, Kumar A, Prasheetha B, Harugop A, Reshma R . COVID 19 Associated Mucormycosis: Preventable Risk Factors Leading to a Better Prognosis: A Case Series. Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):3536-3540. PMC: 9486771. DOI: 10.1007/s12070-022-03163-5. View

Yadav T, Tiwari S, Gupta A, Garg P, Khera P, Rajagopal R . Magnetic Resonance Imaging in Coronavirus Disease - 2019 Associated Rhino-Orbital-Cerebral Mucormycosis (CA-ROCM) - Imaging Analysis of 50 Consecutive Patients. Curr Probl Diagn Radiol. 2021; 51(1):112-120. PMC: 8564981. DOI: 10.1067/j.cpradiol.2021.09.004. View

10.

Shete A, Deshpande S, Sawant J, Warthe N, Thakar M, Madkaikar M . Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis. Immunobiology. 2023; 228(3):152384. PMC: 10089671. DOI: 10.1016/j.imbio.2023.152384. View

11.

Roques M, Chretien M, Favennec C, Lafon I, Ferrant E, Legouge C . Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis. Mycoses. 2016; 59(6):383-90. DOI: 10.1111/myc.12487. View

12.

Farghly Youssif S, Abdelrady M, Thabet A, Abdelhamed M, Gad M, Abu-Elfatth A . COVID-19 associated mucormycosis in Assiut University Hospitals: a multidisciplinary dilemma. Sci Rep. 2022; 12(1):10494. PMC: 9212202. DOI: 10.1038/s41598-022-13443-3. View

13.

Radotra B, Challa S . Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why. Curr Fungal Infect Rep. 2022; 16(4):206-220. PMC: 9520103. DOI: 10.1007/s12281-022-00443-z. View

14.

Muthu V, Rudramurthy S, Chakrabarti A, Agarwal R . Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World. Mycopathologia. 2021; 186(6):739-754. PMC: 8375614. DOI: 10.1007/s11046-021-00584-8. View

15.

Dave T, Nair A, Joseph J, Freitag S . Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review. Orbit. 2022; 41(6):670-679. DOI: 10.1080/01676830.2022.2099428. View

16.

Winn R, Gil-Lamaignere C, Roilides E, Simitsopoulou M, Lyman C, Maloukou A . Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species. J Infect Dis. 2003; 188(4):585-90. DOI: 10.1086/377099. View

17.

Garcia-Vidal C, Viasus D, Carratala J . Pathogenesis of invasive fungal infections. Curr Opin Infect Dis. 2013; 26(3):270-6. DOI: 10.1097/QCO.0b013e32835fb920. View

18.

Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C . Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020; 18(1):206. PMC: 7237880. DOI: 10.1186/s12967-020-02374-0. View

19.

Rao P, Rangankar V, Rohatgi S, Dubey P, Gitay A, Singh A . Predictors of disease severity in COVID-19 associated mucormycosis: impact of HbA1C levels, time lag to mucormycosis onset, and radiologic patterns of paranasal sinuses and spaces involvement. Infect Dis (Lond). 2023; 55(11):755-766. DOI: 10.1080/23744235.2023.2238073. View

20.

Camargo J, Husain S . Immune correlates of protection in human invasive aspergillosis. Clin Infect Dis. 2014; 59(4):569-77. DOI: 10.1093/cid/ciu337. View